{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T07:54:20Z","timestamp":1764402860472,"version":"3.40.5"},"reference-count":47,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","trasci.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.transci.2018.09.017","type":"journal-article","created":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T17:15:14Z","timestamp":1537290914000},"page":"762-767","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Promising utilization areas of therapeutic plasmapheresis in cardiovascular surgery practice"],"prefix":"10.1016","volume":"57","author":[{"given":"Mustafa Serkan","family":"Durdu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet","family":"Cakici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6687-2731","authenticated-orcid":false,"given":"Fatih","family":"Gumus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunseli Cubukcuoglu","family":"Deniz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sinem Civriz","family":"Bozdag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6151-2147","authenticated-orcid":false,"given":"Evren","family":"Ozcinar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7515-8465","authenticated-orcid":false,"given":"Nur Dikmen","family":"Yaman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osman","family":"Ilhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kemalettin","family":"Ucanok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.transci.2018.09.017_bib0005","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/jca.20302","article-title":"Conventional apheresis therapies: a review","volume":"26","author":"Ward","year":"2011","journal-title":"J Clin Apher"},{"key":"10.1016\/j.transci.2018.09.017_bib0010","first-page":"90","article-title":"Plasmapheresis in intensive therapy unit","volume":"42","author":"Szczeklik","year":"2010","journal-title":"Anaesthesiol Intensive Ther"},{"issue":"February 8","key":"10.1016\/j.transci.2018.09.017_bib0015","first-page":"801","article-title":"The third international consensus definitions for Sepsis and septic shock (Sepsis-3)","volume":"23; 315","author":"Mervyn","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.transci.2018.09.017_bib0020","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1378\/chest.101.6.1644","article-title":"The ACCP\/SCCM Consensus Conference Committee. American College of Chest Physicians\/Society of Critical Care Medicine Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis","volume":"101","author":"Bone","year":"1992","journal-title":"Chest"},{"key":"10.1016\/j.transci.2018.09.017_bib0025","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.2215\/CJN.01340406","article-title":"Hepatorenal syndrome: pathophysiology and management","volume":"1","author":"Wadei","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"issue":"June 6","key":"10.1016\/j.transci.2018.09.017_bib0030","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/hep.20687","article-title":"MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation","volume":"41","author":"Alessandria","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.transci.2018.09.017_bib0035","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.echo.2010.05.010","volume":"23","author":"Lawrence","year":"2010","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.transci.2018.09.017_bib0040","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/jca.21265","article-title":"The selective therapeutic apheresis procedures","volume":"28","author":"Amber","year":"2013","journal-title":"J Clin Apher"},{"key":"10.1016\/j.transci.2018.09.017_bib0045","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJM200103083441001","article-title":"Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group: efficacy and safety of recombinant human activated protein C for severe sepsis","volume":"344","author":"Bernard","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transci.2018.09.017_bib0050","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1164\/rccm.2201087","article-title":"Current epidemiology of septic shock: the CUB-rea network","volume":"168","author":"Annane","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.transci.2018.09.017_bib0055","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1056\/NEJMra043632","article-title":"Management of sepsis","volume":"355","author":"Russell","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transci.2018.09.017_bib0060","doi-asserted-by":"crossref","DOI":"10.1097\/MAT.0b013e3182816a75","article-title":"Newly designed CRRT membranes for Sepsis and SIRS\u2014a pragmatic approach for bedside intensivists summarizing the more recent advances: a systematic structured review","author":"Honore","year":"2013","journal-title":"Asaio J"},{"key":"10.1016\/j.transci.2018.09.017_bib0065","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1471-2253-14-24","article-title":"Therapeutic plasma exchange as rescue therapy in severe sepsis and septic shock: retrospective observational single-centre study of 23 patients","volume":"14","author":"Hadem","year":"2014","journal-title":"BMC Anesthesiol"},{"issue":"November (42)","key":"10.1016\/j.transci.2018.09.017_bib0070","doi-asserted-by":"crossref","first-page":"5552","DOI":"10.3748\/wjg.v13.i42.5552","article-title":"Acute renal dysfunction in liver diseases","volume":"13","author":"Betrosian","year":"2007","journal-title":"World J Gastroenterol"},{"issue":"May 5","key":"10.1016\/j.transci.2018.09.017_bib0075","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/0090-6980(77)90212-X","article-title":"The treatment of the hepatorenal syndrome with intra-renal administration of prostaglandin E1","volume":"13","author":"Zusman","year":"1977","journal-title":"Prostaglandins"},{"issue":"September 8","key":"10.1016\/j.transci.2018.09.017_bib0080","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/liv.12549","article-title":"Kidney injury in cirrhosis: pathophysiological and therapeutic aspects of hepatorenal syndromes","volume":"34","author":"Moller","year":"2014","journal-title":"Liver Int"},{"issue":"January 1","key":"10.1016\/j.transci.2018.09.017_bib0085","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1053\/j.gastro.2007.10.055","article-title":"Relationship between activation of the sympathetic nervous system and renal blood flow autoregulation in cirrhosis","volume":"134","author":"Stadlbauer","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.transci.2018.09.017_bib0090","doi-asserted-by":"crossref","first-page":"G970","DOI":"10.1152\/ajpgi.00521.2002","article-title":"Central- and noncentral blood volumes in cirrhosis. Relation to anthropometrics and gender","volume":"284","author":"M\u00f8ller","year":"2003","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.transci.2018.09.017_bib0095","doi-asserted-by":"crossref","first-page":"H2966","DOI":"10.1152\/ajpheart.01227.2006","article-title":"Reduced baroreflex sensitivity in alcoholic cirrhosis:relations to hemodynamics and humoral systems","volume":"292","author":"M\u00f8ller","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.transci.2018.09.017_bib0100","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/hep.21940","article-title":"Lack of renal improvement with nonselective endothelin antagonism with tezosentan in type 2 hepatorenal syndrome","volume":"47","author":"Wong","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.transci.2018.09.017_bib0105","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s12072-008-9100-3","article-title":"Pathogenetic background for treatment of ascites and hepatorenal syndrome","volume":"2","author":"M\u00f8ller","year":"2008","journal-title":"Hepatol Int"},{"key":"10.1016\/j.transci.2018.09.017_bib0110","series-title":"Ascites and renal dysfunction in liver disease","first-page":"139","article-title":"The systemic circulation in cirrhosis","author":"M\u00f8ller","year":"2005"},{"key":"10.1016\/j.transci.2018.09.017_bib0115","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/0016-5085(88)90441-6","article-title":"Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites","volume":"94","author":"Llach","year":"1988","journal-title":"Gastroenterology"},{"issue":"October 10","key":"10.1016\/j.transci.2018.09.017_bib0120","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1093\/oxfordjournals.eurheartj.a015142","article-title":"Haemodynamic, neuroendocrine and metabolic correlates of circulating cytokine concentrations in congestive heart failure","volume":"18","author":"Lommi","year":"1997","journal-title":"Eur Heart J"},{"key":"10.1016\/j.transci.2018.09.017_bib0125","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1136\/gut.2009.180570","article-title":"Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites","volume":"59","author":"Krag","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.transci.2018.09.017_bib0130","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1111\/j.1600-6143.2004.00500.x","article-title":"National conference to assess antibody-mediated rejection in solid organ transplantation","volume":"4","author":"Takemoto","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transci.2018.09.017_bib0135","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S1053-2498(99)00022-4","article-title":"Plasmapheresis with intravenous immunoglobulin G is effective in patients with elevated panel reactive antibody prior to cardiac transplantation","volume":"18","author":"Pisani","year":"1999","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.transci.2018.09.017_bib0140","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.healun.2007.01.027","article-title":"Successful management of antibodymediated cardiac allograft rejection with combined immunoadsorption and anti-CD20 monoclonal antibody treatment: case report and literature report","volume":"26","author":"Kaczmarek","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.transci.2018.09.017_bib0145","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.healun.2005.03.019","article-title":"Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection","volume":"24","author":"Stewart","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.transci.2018.09.017_bib0150","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.healun.2010.11.003","article-title":"Report from a consensus conference on antibody-mediated rejection in heart transplantation","volume":"30","author":"Kobashigawa","year":"2011","journal-title":"J Heart Lung Transplant"},{"issue":"Suppl. 9","key":"10.1016\/j.transci.2018.09.017_bib0155","first-page":"II294","article-title":"Pretransplant panel reactive-antibody screens. Are they truly a marker for poor outcome after cardiac tranplantation?","volume":"94","author":"Kobashigawa","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.transci.2018.09.017_bib0160","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.healun.2011.06.005","article-title":"Allosensitization and outcomes in pediatric heart transplantation","volume":"30","author":"Mahle","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.transci.2018.09.017_bib0165","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1681\/ASN.V133779","article-title":"Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification","volume":"13","author":"Mauiyyedi","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.transci.2018.09.017_bib0170","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1172\/JCI118297","article-title":"Immunoglobulin prevents complement-mediated hyperacute rejection in swineto-primate xenotransplantation","volume":"96","author":"Magee","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.transci.2018.09.017_bib0175","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2215\/CJN.01651105","article-title":"Presensitization: the problem and its management","volume":"1","author":"Jordan","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.transci.2018.09.017_bib0180","first-page":"151","article-title":"Clinical pathologic features of humoral rejection in cardiac allografts","volume":"14","author":"Lones","year":"1995","journal-title":"J Heart Lung Transplant"},{"issue":"March (3)","key":"10.1016\/j.transci.2018.09.017_bib0185","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S1053-2498(00)00211-4","article-title":"Plasmapheresis and cyclophosphamide in the treatment of humoral rejection after heart transplantation","volume":"20","author":"Grauhan","year":"2001","journal-title":"J Heart Lung Transplant"},{"issue":"6","key":"10.1016\/j.transci.2018.09.017_bib0190","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/jca.20264","article-title":"Therapeutic plasma exchange a potential strategy for patients with advanced heart failure","volume":"25","author":"Torre-Amione","year":"2010","journal-title":"J Clin Apher"},{"key":"10.1016\/j.transci.2018.09.017_bib0195","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jacc.2012.02.073","article-title":"Independent and incremental role of quantative right ventricular evaluation for the prediction of right ventricular failure after left ventricular assist device implantation","volume":"60","author":"Grant","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.transci.2018.09.017_bib0200","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ccl.2012.03.008","article-title":"Right ventricular failure in patients with left ventricular asist devices","volume":"30","author":"Rich","year":"2012","journal-title":"Cardiol Clin"},{"key":"10.1016\/j.transci.2018.09.017_bib0205","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.jtcvs.2010.08.010","article-title":"Acute impact of left ventricular unloading by left ventricular assist device on the right ventricle geometry and function: effect of nitric oxide inhalation","volume":"141","author":"Kukucka","year":"2011","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.transci.2018.09.017_bib0210","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1213\/ane.0b013e31818d8b92","article-title":"The right ventricle in cardiac surgery, a perioperative perspective: II. Pathophysiology, clinical importance, and management","volume":"108","author":"Haddad","year":"2009","journal-title":"Anesth Analg"},{"issue":"December (12)","key":"10.1016\/j.transci.2018.09.017_bib0215","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.healun.2008.08.012","article-title":"Tricuspid incompetence and geometry of the right ventricle as predictors of right ventricular function after implantation of a left ventricular assist device","volume":"27","author":"Potapov","year":"2008","journal-title":"J Heart Lung Transplant"},{"issue":"July (7)","key":"10.1016\/j.transci.2018.09.017_bib0220","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1253\/circj.CJ-09-0748","article-title":"Complete elimination of cardiodepressant IgG3 autoantibodies by immunoadsorption in patients with severe heart failure","volume":"74","author":"Baba","year":"2010","journal-title":"Circ J"},{"key":"10.1016\/j.transci.2018.09.017_bib0225","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jacc.2012.02.073","article-title":"Independent and incremental role of quantitative right ventricular evaluation for the prediction of right ventricular failure after left ventricular assist device implantation","volume":"60","author":"Grant","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"June (3)","key":"10.1016\/j.transci.2018.09.017_bib0230","first-page":"149","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice-evidence-Based approach from the writing committee of the american society for apheresis: the seventh special issue","volume":"31","author":"Schwartz","year":"2016","journal-title":"J Clin Apher"},{"issue":"February (2)","key":"10.1016\/j.transci.2018.09.017_bib0235","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/aor.12734","article-title":"Impact of therapeutic plasma exchange on hemodynamic parameters in medical intensive care unit patients: an observational study","volume":"41","author":"Lahmer","year":"2017","journal-title":"Artif Organs"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050218302271?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050218302271?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T21:22:12Z","timestamp":1662067332000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050218302271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S1473050218302271"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2018.09.017","relation":{},"ISSN":["1473-0502"],"issn-type":[{"type":"print","value":"1473-0502"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Promising utilization areas of therapeutic plasmapheresis in cardiovascular surgery practice","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2018.09.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}